Mersana Therapeutics/ US59045L1061 /
2024-04-19 4:59:12 PM | Chg. -0.04 | Volume | Bid4:59:26 PM | Ask4:59:26 PM | High | Low |
---|---|---|---|---|---|---|
3.30USD | -1.20% | 9,502 Turnover: 31,353.23 |
3.28Bid Size: 117 | 3.30Ask Size: 600 | 3.34 | 3.21 |
GlobeNewswire
04-04
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
02-28
Mersana Therapeutics Provides Business Update and Announces Fourth Quarter and Full Year 2023 Financ...
GlobeNewswire
02-21
Mersana Therapeutics to Host Fourth Quarter and Year End 2023 Conference Call on February 28, 2024
GlobeNewswire
02-01
Mersana Therapeutics to Participate in Guggenheim’s 6th Annual Biotechnology Conference
GlobeNewswire
01-05
Mersana Therapeutics Announces Business Updates, Expected 2024 Milestones and Upcoming Presentation ...
GlobeNewswire
2023-12-01
Mersana Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
2023-11-07
Mersana Therapeutics Provides Business Update and Announces Third Quarter 2023 Financial Results
GlobeNewswire
2023-10-31
Mersana Therapeutics to Host Third Quarter 2023 Conference Call on November 7, 2023
GlobeNewswire
2023-10-31
Mersana Therapeutics Announces FDA has Lifted Clinical Hold on Phase 1 Clinical Trial of XMT-2056
Newsfile Corp
2022-10-21
NanoTomer's New Cancer Report: Early Cancer Diagnosis and Increasing Survival Rate
GlobeNewswire
2022-03-15
Mersana Therapeutics to Present an Analysis from the Expansion Cohort of the Phase 1 Trial of Upifit...
GlobeNewswire
2022-03-02
Mersana Therapeutics to Present at the Cowen 42nd Annual Health Care Conference
GlobeNewswire
2022-02-28
Mersana Therapeutics Announces Fourth Quarter and Full Year 2021 Financial Results and Provides Busi...
GlobeNewswire
2022-02-22
Mersana Therapeutics to Host Conference Call Announcing Fourth Quarter and Year End 2021 Financial R...
GlobeNewswire
2022-02-03
Mersana Therapeutics Announces Research Collaboration and License Agreement with Janssen to Advance ...
GlobeNewswire
2022-01-05
Mersana Therapeutics to Present at the 40th Annual J.P. Morgan Healthcare Conference
GlobeNewswire
2021-12-02
Mersana Therapeutics Named to 2021 List of Top Places to Work in Massachusetts by The Boston Globe
GlobeNewswire
2021-11-23
Mersana Therapeutics to Participate in the Upcoming 4th Annual Evercore ISI HealthCONx Conference
GlobeNewswire
2021-11-10
Mersana Therapeutics to Present at the Upcoming Stifel 2021 Virtual Healthcare Conference
GlobeNewswire
2021-11-09
Mersana Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update